|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.48 CNY | +1.72% |
|
-9.69% | -13.31% |
Dizal (Jiangsu) Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported net loss was CNY 510.1 million compared to CNY 466.39 million a year ago. Basic loss per share from continuing operations was CNY 1.26 compared to CNY 1.3 a year ago.
Diluted loss per share from continuing operations was CNY 1.26 compared to CNY 1.3 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -13.31% | 2.38B | |
| +5.66% | 111B | |
| +11.23% | 105B | |
| -0.38% | 21.93B | |
| -12.15% | 22.34B | |
| -7.66% | 18.59B | |
| -36.52% | 18.12B | |
| -10.09% | 16.96B | |
| +3.33% | 13.7B | |
| +36.58% | 12.45B |
DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD. 
